Cat. #156568
Anti-CD45RC [OX22]
Cat. #: 156568
Unit size: 100 ug
Target: CD45RC
Class: Monoclonal
Application: FACS ; IHC
Reactivity: Rat
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Medical Research Council; University of Oxford
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CD45RC [OX22]
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Rat
- Host: Mouse
- Application: FACS ; IHC
- Description: The antibody reacts mainly with high molecular weight (190-220kDa) form of leukocyte common antigen. Labels all B lymphocytes and 50% of bone marrow cells and 2% of thymocytes. The antibody is directed against CD8+ve T, NK and 75% of CD4+ve cells. Same distribution as OX-32: antibodies do not compete.
- Immunogen: PHA activated rat lymph node cells
- Myeloma used: NS1
- Recommended controls: IgG1
Target Details
- Target: CD45RC
- Target background: The antibody reacts mainly with high molecular weight (190-220kDa) form of leukocyte common antigen. Labels all B lymphocytes and 50% of bone marrow cells and 2% of thymocytes. The antibody is directed against CD8+ve T, NK and 75% of CD4+ve cells. Same distribution as OX-32: antibodies do not compete.
Applications
- Application: FACS ; IHC
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Shipping at 4° C
References
- Spickett et al. 1983. J Exp Med. 158(3):795-810. PMID: 6224884.
